Based on the glutamate hypothesis of schizophrenia,an agonist for glutamate might…

Question

Quizplus · Accepted Answer

The glutamate hypothesis suggests that schizophrenia may be caused by low levels of glutamate activity in certain brain regions. Therefore, an agonist for glutamate could increase glutamate activity and improve symptoms. Several clinical trials have shown that drugs that enhance glutamate activity such as glycine, D-serine, and sarcosine can reduce symptoms of schizophrenia, providing evidence for the effectiveness of this approach.

Based on the Glutamate Hypothesis of Schizophrenia,an Agonist for Glutamate